Literature DB >> 9071904

Long-term effects of fenretinide on retinal function.

A Decensi1, V Fontana, M Fioretto, G Rondanina, R Torrisi, M A Orengo, A Costa.   

Abstract

The long-term effects of the synthetic retinoid fenretinide (4-HPR) on retinal function were studied by electroretinogram (ERG) in 24 women treated for a median of 30.5 months and in 18 untreated controls belonging to a phase III intervention trial. The six outcome measures were: a wave implicit time, peak-to-peak amplitude and implicit time of b wave following both cone stimulation and maximal cone-rod stimulation in the dark-adapted eye. Multivariate analysis of covariance was applied to evaluate the joint effect on the whole set of ERG measures taking into account their inter-relationship. Predictive factors with a significant effect on ERG measures were: (1) a qualitative interaction between age and treatment duration and (2) the squared (parabolic) function of plasma retinol. Individually, the b wave implicit time following cone stimulation was the only ERG measure significantly influenced by the predictors, indicating a primary effect of 4-HPR on retinal photoreceptor sensitivity without significant alterations of the inner nuclear layer. Thus, in contrast to previous reports at higher dose, administration of 4-HPR at 200 mg/day seems to exert subtle alterations of retinal function as measured by ERG.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9071904     DOI: 10.1016/s0959-8049(96)00351-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  4 in total

Review 1.  Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule.

Authors:  Rosa Luisa Potenza; Pietro Lodeserto; Isabella Orienti
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

2.  A rapid, sensitive and selective liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry method for determination of fenretinide (4-HPR) in plasma.

Authors:  James I Lee; Vu T Nguyen; Mei-Ling Chen; Peter C Adamson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-11-04       Impact factor: 3.205

3.  Total rod ERG suppression with high dose compassionate Fenretinide usage.

Authors:  Michael F Marmor; Atul Jain; Darius Moshfeghi
Journal:  Doc Ophthalmol       Date:  2008-06-04       Impact factor: 2.379

Review 4.  Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).

Authors:  Ali Saeed; Robin P F Dullaart; Tim C M A Schreuder; Hans Blokzijl; Klaas Nico Faber
Journal:  Nutrients       Date:  2017-12-29       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.